DeVilbiss Healthcare signed an exclusive global distribution agreement with InnoMed Technologies and RespCare to sell the Hybrid, Bravo and Nasal-Aire CPAP interfaces for use in obstructive sleep apnea (OSA) treatment.
“We are excited to offer our customers this innovative line of CPAP interfaces” “There is a natural synergy between the InnoMed/RespCare interfaces and our new IntelliPAP line of flow generators,” said DeVilbiss CEO & President Kees Regeling.
“We are both focused on delivering products that improve patient compliance while allowing providers and clinicians to optimize their business and improve efficiencies,” said InnoMed CEO Sanjay Chandran of both companies.
DeVilbiss will contact InnoMed/RespCare customers over coming weeks to provide new ordering information, but customers also can call DeVilbiss customer service at 800-338-1988 to order the Hybrid, Bravo or NasalAire interfaces and DeVilbiss is offering more information abut the interfaces at its website, www.devilbisshealthcare.com.
